Novo Nordisk A/S Company Profile

Aggregated data from the web about Novo Nordisk A/S

Company Name	Novo Nordisk A/S
Website	https://www.novonordisk.com
Snippet	Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Type	Aktieselskab
Founded	1923
Revenue	DKK 122.02 billion (2019)[1]
Website	www.novonordisk.com
Industry	Pharmaceuticals, Health care
Products	Ozempic, Ryzodeg, Victoza, NovoEight, Activella, Novolin, Levemir, NovoSeven, Norditropin, Tresiba, Xultophy, NovoRapid, Fiasp, Saxenda
Traded as	Nasdaq Copenhagen: NOVO BNYSE: NVO
Key people	Helge Lund (Chairman)Lars Fruergaard Jørgensen (President & CEO)
Net income	DKK 38.951 billion (2019)[1]
Headquarters	Bagsværd, Denmark
Total assets	DKK 125.612 billion (2019)[1]
Total equity	DKK 57.593 billion (2019)[1]
Operating income	DKK 52.483 billion (2019)[1]
Number of employees	45,971 (2021)[2]

Novo Nordisk A/S is part of the Denmark company list

Novo Nordisk A/S is part of the Health Care company list

Novo Nordisk A/S is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.